• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植物抗宿主病小鼠模型:临床转化视角

Graft-Versus-Host Disease Mouse Models: A Clinical-Translational Perspective.

作者信息

Elliott Jessica, Koldej Rachel, Khot Amit, Ritchie David

机构信息

ACRF Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, VIC, Australia.

Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

出版信息

Methods Mol Biol. 2025;2907:1-56. doi: 10.1007/978-1-0716-4430-0_1.

DOI:10.1007/978-1-0716-4430-0_1
PMID:40100591
Abstract

A variety of graft-versus-host disease (GVHD) models have been developed in mice for the purpose of allowing laboratory investigation of the pathobiology, prevention, and treatment of GVHD in humans. While such models are crucial in advancing our knowledge in this field, there are some key limitations that need to be considered when translating laboratory discoveries into the clinical context. This chapter will discuss current clinical practices in transplantation and GVHD and the relative strengths and weaknesses of mouse models that attempt to replicate these states.

摘要

为了能够在实验室中研究人类移植物抗宿主病(GVHD)的病理生物学、预防和治疗,已经在小鼠中建立了多种GVHD模型。虽然这些模型对于推动我们在该领域的知识发展至关重要,但在将实验室发现转化为临床实际应用时,需要考虑一些关键的局限性。本章将讨论移植和GVHD的当前临床实践,以及试图复制这些状态的小鼠模型的相对优缺点。

相似文献

1
Graft-Versus-Host Disease Mouse Models: A Clinical-Translational Perspective.移植物抗宿主病小鼠模型:临床转化视角
Methods Mol Biol. 2025;2907:1-56. doi: 10.1007/978-1-0716-4430-0_1.
2
Allogeneic Mouse Models of Graft-Versus-Host Disease.移植物抗宿主病的同种异体小鼠模型
Methods Mol Biol. 2025;2907:127-140. doi: 10.1007/978-1-0716-4430-0_6.
3
Xenogeneic Animal Models of Graft-Versus-Host Disease.移植物抗宿主病的异种动物模型
Methods Mol Biol. 2025;2907:57-70. doi: 10.1007/978-1-0716-4430-0_2.
4
Transplantation and Monitoring of a Murine Minor Histocompatibility Antigen-Mismatched Model of Graft-Versus-Host Disease.小鼠次要组织相容性抗原错配的移植物抗宿主病模型的移植与监测
Methods Mol Biol. 2025;2907:141-160. doi: 10.1007/978-1-0716-4430-0_7.
5
Editorial on Translational Research in Graft-Versus-Host Disease (GVHD) and Graft-Versus-Tumor (GVT) Effect After Allogeneic Hematopoietic Cell Transplantation.异基因造血细胞移植后移植物抗宿主病(GVHD)及移植物抗肿瘤(GVT)效应的转化研究述评
Front Immunol. 2022 Jun 8;13:948720. doi: 10.3389/fimmu.2022.948720. eCollection 2022.
6
Acute graft-vs-host disease: pathobiology and management.急性移植物抗宿主病:病理生物学与管理
Exp Hematol. 2001 Mar;29(3):259-77. doi: 10.1016/s0301-472x(00)00677-9.
7
Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?急性和慢性移植物抗宿主病的临床前模型:它们对成功的临床转化有多大的预测性?
Blood. 2016 Jun 23;127(25):3117-26. doi: 10.1182/blood-2016-02-699082. Epub 2016 Mar 18.
8
Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Host Disease.用于预防胃肠道移植物宿主病的转化临床策略。
Front Immunol. 2021 Nov 26;12:779076. doi: 10.3389/fimmu.2021.779076. eCollection 2021.
9
Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL.异基因造血干细胞移植后的移植物抗宿主效应:移植物抗宿主病和移植物抗白血病效应
Curr Opin Immunol. 1996 Oct;8(5):674-80. doi: 10.1016/s0952-7915(96)80085-9.
10
Preclinical modeling of hematopoietic stem cell transplantation - advantages and limitations.造血干细胞移植的临床前建模——优势与局限
FEBS J. 2016 May;283(9):1595-606. doi: 10.1111/febs.13612. Epub 2015 Dec 31.

本文引用的文献

1
Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients.在再生障碍性贫血患者进行异基因干细胞移植时,添加鲁索利替尼以预防标准移植物抗宿主病。
Bone Marrow Transplant. 2024 Jul;59(7):997-1005. doi: 10.1038/s41409-024-02266-7. Epub 2024 Apr 5.
2
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?在异基因造血干细胞移植中,使用抗胸腺细胞球蛋白或移植后环磷酰胺来预防移植物抗宿主病?
Leukemia. 2024 May;38(5):1156-1163. doi: 10.1038/s41375-024-02225-7. Epub 2024 Mar 27.
3
A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China.
中国一项贝洛索利单抗治疗二线及以上系统性治疗失败的慢性移植物抗宿主病患者的 II 期临床研究。
BMC Med. 2024 Mar 26;22(1):142. doi: 10.1186/s12916-024-03348-5.
4
Long-Term Clinical Outcomes and B Cell Immune Reconstitution Following Allo-HCT With Prophylactic, Post-Transplant Rituximab.异基因造血干细胞移植后预防性使用利妥昔单抗的长期临床结局和 B 细胞免疫重建。
Transplant Cell Ther. 2024 May;30(5):518.e1-518.e13. doi: 10.1016/j.jtct.2024.02.025. Epub 2024 Mar 6.
5
Ruxolitinib for the treatment of acute and chronic graft-versus-host disease in children: a systematic review and individual patient data meta-analysis.芦可替尼治疗儿童急性和慢性移植物抗宿主病:系统评价和个体患者数据分析荟萃分析。
Bone Marrow Transplant. 2024 Jun;59(6):765-776. doi: 10.1038/s41409-024-02252-z. Epub 2024 Feb 24.
6
Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease.肠道微生物群、微生物衍生代谢物与移植物抗宿主病。
Cancer Med. 2024 Feb;13(3):e6799. doi: 10.1002/cam4.6799. Epub 2024 Jan 18.
7
Altered Serum Alpha1-Antitrypsin Protease Inhibition before and after Clinical Hematopoietic Stem Cell Transplantation: Association with Risk for Non-Relapse Mortality.临床造血干细胞移植前后血清α1-抗胰蛋白酶蛋白酶抑制物的改变:与非复发死亡率风险的关联。
Int J Mol Sci. 2023 Dec 28;25(1):422. doi: 10.3390/ijms25010422.
8
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease.ROCK1/2 信号通路促进皮质类固醇耐药性急性移植物抗宿主病。
Nat Commun. 2024 Jan 10;15(1):446. doi: 10.1038/s41467-024-44703-7.
9
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.造血系统恶性肿瘤患者干细胞移植后移植物抗宿主病的预防和治疗:欧洲血液和骨髓移植学会更新的共识建议。
Lancet Haematol. 2024 Feb;11(2):e147-e159. doi: 10.1016/S2352-3026(23)00342-3. Epub 2024 Jan 3.
10
Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant: An Open-Label Randomized Clinical Trial.异体造血干细胞移植后预防慢性移植物抗宿主病的间充质干细胞:一项开放标签随机临床试验。
JAMA Oncol. 2024 Feb 1;10(2):220-226. doi: 10.1001/jamaoncol.2023.5757.